A retrospective, observational study of Abiraterone-acetate and Enzalutamide in patients with advanced prostate cancer
Latest Information Update: 19 Feb 2024
At a glance
- Drugs Abiraterone acetate (Primary) ; Enzalutamide (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 03 Oct 2016 New trial record